Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis.
第一作者:
Rama Subba Rao,Vidadala
第一单位:
Department of Chemistry, University of Washington , Seattle, Washington 98195, United States.
作者:
医学主题词
投药, 口服(Administration, Oral);动物(Animals);抗原虫药(Antiprotozoal Agents);中枢神经系统(Central Nervous System);疾病模型, 动物(Disease Models, Animal);狗(Dogs);剂量效应关系, 药物(Dose-Response Relationship, Drug);药物设计(Drug Design);快速延迟整流钾通道(Ether-A-Go-Go Potassium Channels);女(雌)性(Female);直鼻猴亚目(Haplorhini);小鼠(Mice);小鼠, 近交BALB C(Mice, Inbred BALB C);分子结构(Molecular Structure);寄生虫敏感性试验(Parasitic Sensitivity Tests);蛋白激酶抑制剂(Protein Kinase Inhibitors);蛋白激酶类(Protein Kinases);大鼠(Rats);大鼠, Sprague-Dawley(Rats, Sprague-Dawley);构效关系(Structure-Activity Relationship);弓形虫属(Toxoplasma);弓形虫病(Toxoplasmosis)
DOI
10.1021/acs.jmedchem.6b00760
PMID
27309760
发布时间
2018-11-13
- 浏览72
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



